Ondansetron Injection

Form: Injection

Strength: 2 mg/2 mL, 4 mg/2 mL , 8 mg/4 mL

Reference Brands: Zofran(US & EU)

Category: Oncology Cancer Care

Ondansetron Injection 2 mg/2 mL, 4 mg/2 mL, and 8 mg/4 mL is an essential medication in oncology for the prevention of chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and vomiting (RINV). As a 5-HT3 receptor antagonist, it effectively blocks serotonin, reducing nausea and vomiting associated with highly emetogenic chemotherapy. Ondansetron is available in IV solution form and is widely used in oncology B2B distribution across the U.S. and EU. It plays a vital role in improving patient comfort during cancer treatment.